Qomel expands with Kan Medical stake

Saudi-listed Qomel Company has agreed to acquire a 75 per cent stake in Kan Medical Company in a transaction valued at around SAR3 million, marking a strategic move to deepen its footprint in the Kingdom’s healthcare services sector and accelerate consolidation in a fragmented market.

The deal, financed through Qomel’s internal resources, underscores a broader trend among mid-sized healthcare providers in Saudi Arabia seeking to scale operations, enhance service offerings and align with the government’s long-term healthcare transformation agenda. The acquisition gives Qomel majority control over Kan Medical’s operations, allowing it to integrate services, optimise costs and expand patient reach across key urban centres.

Qomel, listed on the Saudi stock exchange, has been steadily building its presence in outpatient care and specialised medical services. Industry analysts note that the company has adopted a growth strategy focused on targeted acquisitions of smaller providers with established local networks. Kan Medical, though relatively modest in size, is understood to operate clinics catering to primary and specialised care segments, making it an attractive bolt-on acquisition.

Saudi Arabia’s healthcare sector has undergone significant restructuring as part of Vision 2030, which aims to increase private sector participation, improve service quality and reduce reliance on public funding. The government has encouraged mergers and acquisitions to create more efficient healthcare networks capable of meeting rising demand driven by population growth, urbanisation and an increasing prevalence of chronic diseases.

Within this context, Qomel’s acquisition reflects a broader wave of consolidation. Private healthcare operators are seeking to expand capacity while improving operational efficiency through economies of scale. Smaller providers such as Kan Medical often face constraints related to capital investment, technology adoption and regulatory compliance, making partnerships with larger entities a viable pathway for growth.

Market participants indicate that transactions of this scale, while modest in value, play a crucial role in reshaping the competitive landscape. By integrating Kan Medical into its portfolio, Qomel is expected to enhance its service mix and potentially introduce new specialities, while also leveraging centralised procurement and administrative systems to reduce overhead costs.

The financial structure of the deal, relying on internal funding, signals Qomel’s relatively strong balance sheet and cautious approach to leverage. Analysts suggest that maintaining financial flexibility is critical in a sector characterised by ongoing regulatory reforms and evolving reimbursement frameworks. Companies that avoid excessive debt are better positioned to navigate policy shifts and invest in technology upgrades.

Saudi Arabia’s push to privatise segments of its healthcare system has attracted increasing interest from domestic and regional investors. The government has outlined plans to cluster healthcare services and eventually transition many facilities to private operators, creating opportunities for companies like Qomel to expand through acquisitions and partnerships. The focus has also shifted towards preventive care, digital health solutions and specialised treatment centres, areas where scale and investment capacity provide a competitive advantage.

Kan Medical’s integration into Qomel’s network is expected to support these priorities. Healthcare providers are increasingly investing in electronic health records, telemedicine platforms and advanced diagnostic tools to improve patient outcomes and operational efficiency. Larger groups can spread these costs across multiple facilities, making acquisitions an effective strategy for smaller operators seeking access to such capabilities.

At the same time, consolidation raises questions about market concentration and pricing. Regulators are tasked with ensuring that increased private sector participation does not lead to higher costs for patients or reduced access to essential services. The balance between efficiency gains and affordability remains a central concern as the sector evolves.

Healthcare demand in Saudi Arabia continues to rise, driven by demographic shifts and lifestyle-related health conditions such as diabetes and cardiovascular diseases. This has placed pressure on both public and private providers to expand capacity and improve service delivery. Strategic acquisitions like Qomel’s stake in Kan Medical are seen as part of the solution, enabling providers to respond more effectively to growing demand.

Industry observers also point to the role of insurance coverage expansion in shaping the market. Mandatory health insurance schemes have increased patient access to private healthcare services, boosting utilisation rates and encouraging providers to invest in new facilities and services. Companies with diversified networks are better positioned to capture this demand, further incentivising consolidation.